Fidelity MSCI Health Care Index (FHLC) ETF Holdings & Analysis
ETFOther
$83.78+0.80%
52-week range$83.78
$64.30$85.46
What FHLC does
Seeks to achieve investment results that correspond to the MSCI USA IMI Health Care Index.
Fund profile
Category
Other
AUM
$3.42B
Holdings
10
52-week high
$85.46
52-week low
$64.30
Top holdings
| Holding | Weight | |
|---|---|---|
| ELI LILLY & CO | 12.76% | |
| JOHNSON & JOHNSON | 8.82% | |
| ABBVIE INC | 6.24% | |
| MERCK & CO INC NEW | 5.03% | |
| UNITEDHEALTH GROUP INC | 4.87% | |
| AMGEN INC | 3.20% | |
| THERMO FISHER SCIENTIFIC INC | 3.16% | |
| ABBOTT LABORATORIES | 2.65% | |
| GILEAD SCIENCES INC | 2.50% | |
| PFIZER INC | 2.23% |
Sector allocation
| Cash & Others | 0.44% |
| Financial Services | 0.03% |
| Healthcare | 98.92% |
| Technology | 0.61% |
Geographic allocation
| United States | 96.95% |
| Ireland | 2.24% |
| United Kingdom | 0.37% |
| Other | 0.21% |
| Canada | 0.10% |
| Switzerland | 0.08% |
| Netherlands | 0.06% |
PortView Portfolio Insights
PortView analyzes how FHLC fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze FHLC in PortView →Related securities
Related stocks
Frequently asked questions
- What does FHLC track?
- FHLC is the Fidelity MSCI Health Care Index ETF, a Other ETF.
- What is the expense ratio of FHLC?
- Expense ratio data for FHLC is shown on the page when available from our data provider.
- What are the largest holdings in FHLC?
- Top holdings include LLY, JNJ, ABBV, MRK, UNH.
- How can PortView analyze FHLC overlap with other ETFs?
- PortView computes the holdings overlap between FHLC and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.